The most investigated gene in IBD was HLA-DQA1*05, due to two variants in HLA genes (rs2097432 CC + CT and rs2395185 GG), which have been associated with a response to anti-TNF drugs. The gene discussed is HLA-DQA1; the disease is inflammatory bowel disease.